IMNM Form 144: Affiliates List Sales of 100,000 Shares

IMNM files Form 144 reporting intended sale of Common Stock by affiliates.

Rhea-AI Filing Summary

IMNM files Form 144 reporting intended sale of Common Stock by affiliates. The filing lists multiple planned or recent transactions totaling specific share amounts: 100,000 shares reported as "Securities To Be Sold" (private placement proceeds listed as Cash) with an original issuance date of 10/03/2023. The excerpt also shows recent sales by affiliates: two entries of 100,000 shares with trade dates 06/30/2026 and 07/02/2026, and an additional affiliate sale of 1,050 shares on 06/30/2026.

Insights

Securities Compliance Attorney

Form 144 notifies the market of affiliate resale activity and planned private placement resale.

The filing lists a private placement issuance dated 10/03/2023 of 100,000 shares described as sold for Cash. It also records resale transactions by affiliate entities on 06/30/2026 and 07/02/2026, including two 100,000-share entries and one 1,050-share entry.

These notices are procedural disclosures under the securities rules. The timing, method of sale, and recipient of proceeds beyond "Cash" are not detailed in the excerpt; subsequent SEC filings or broker reports would show execution specifics.

Key Figures

Registered/To be sold: 100,000 shares Affiliate sale: 100,000 shares Affiliate sale: 100,000 shares +2 more

5 metrics

Registered/To be sold 100,000 shares Securities To Be Sold (private placement) dated 10/03/2023

Affiliate sale 100,000 shares Sale reported by ABHMC II LLC with trade date 06/30/2026

Affiliate sale 100,000 shares Sale reported with trade date 07/02/2026

Affiliate sale (small) 1,050 shares Sale reported by ARSENAL BRIDGE VENTURE II-B LLC with trade date 06/30/2026

Exchange Nasdaq Market listing for the Common shares

Key Terms

Form 144, Private Placement, Affiliate

3 terms

Form 144 regulatory

"144: Securities To Be Sold"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Private Placement financial

"Private Placement | Issuer | 10/03/2023"

A private placement is a sale of securities directly to a selected group of investors, typically institutions or accredited investors, instead of through a public offering. It lets a company raise money faster and with fewer regulatory steps; for existing shareholders it matters because the newly issued shares, often sold at a discount, increase the share count and can dilute their ownership.

Affiliate regulatory

"ABHMC II LLC ... entries showing sales by affiliates"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does IMNM's Form 144 disclose about the sale?

It discloses an intended resale of 100,000 shares originating from a 10/03/2023 private placement, and affiliate resale entries of 100,000, 100,000, and 1,050 shares on 06/30/2026 and 07/02/2026.

Who are the selling parties listed in the IMNM Form 144 excerpt?

The excerpt names affiliate entities including ABHMC II LLC and ARSENAL BRIDGE VENTURE II-B LLC as parties tied to the reported sales on the listed dates and share amounts.

Does the Form 144 state how proceeds are used for IMNM (symbol IMNM)?

The filing labels the consideration as Cash for the private placement resale entry, but it does not disclose any use‑of‑proceeds details in the provided excerpt.

Are the reported share amounts in IMNM Form 144 executed trades or notices of intent?

Form 144 entries can be notices of intended resale or record of recent sales; this excerpt shows both a listed "Securities To Be Sold" entry and recent sales with trade dates, indicating both notice and recorded transactions.

What exchanges or market identifiers appear in the IMNM excerpt?

The excerpt lists Nasdaq as the market venue and includes a reference to 100000 and other numeric fields; no execution venue details beyond Nasdaq are provided for each sale in the excerpt.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/06/2026 - 05:37 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002129593
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Immunome, Inc.
SEC File Number	001-39580
Address of Issuer	18702 N. CREEK PARKWAY SUITE 100 BOTHEL WASHINGTON 98011
Phone	4259397410
Name of Person for Whose Account the Securities are To Be Sold	ABHMC II, LLC
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Shareholder

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Merrill Lynch 555 California Street 18th Floor San Francisco CA 94104	100000	2361000	113250394	07/06/2026	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	10/03/2023	Private Placement	Issuer			100000	10/03/2023	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
ABHMC II LLC 4305 AVENUE D AUSTIN TX 78751	Common	06/30/2026	100000	2112450
ABHMC II LLC 4305 AVENUE D AUSTIN TX 78751	Common	07/02/2026	100000	2258949
ARSENAL BRIDGE VENTURE II-B LLC 4305 AVENUE D AUSTIN TX 78751	Common	06/30/2026	1050	22180.72

144: Remarks and Signature

Remarks
Date of Notice	07/06/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	03/31/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	James B. Graham
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)